PoliticalRepoPoliticalRepo

Bill · HR

H.R. 3162 (119th)

Affordable and Safe Prescription Drug Importation Act of 2025

Original

referredUnited States· United States Congress· EN

Introduced

1 May 2025

Last action

1 May 2025 · Introduced

Status

Referred to the House Committee on Energy and Commerce.

Sponsors

Janice Schakowsky, Steve Cohen, Lloyd Doggett, Ilhan Omar, Chellie Pingree, Mark Pocan, Yassamin Ansari, Del. Norton, Eleanor Holmes [D-DC-At Large], Greg Casar

Subjects

Healthcare, European Union

Source updated

4 August 2026

Healthcare · European Union

Summary

Affordable and Safe Prescription Drug Importation Act of 2025 This bill expands the categories of prescription drugs that may be imported into the United States and the countries from which such drugs may be imported. Current law allows the Department of Health and Human Services (HHS) to authorize importation of certain eligible prescription drugs from Canada if HHS certifies that doing so would pose no additional risk to public health and safety, among other requirements. HHS long declined to make the requisite certification, citing safety concerns (e.g., contamination, counterfeiting), but ultimately made the certification in 2020 and has since approved one state plan to import drugs. The bill removes the certification requirement and requires HHS to issue regulations that permit importation of qualifying prescription drugs from the United Kingdom, Switzerland, and member states of the European Union, in addition to Canada. After one year, if HHS determines that importation of drugs from these countries has been conducted safely, HHS may authorize importation from other countries that meet certain requirements. The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin. Further, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS. Finally, the bill imposes criminal penalties for websites that sell counterfeit drugs or dispense drugs without a required prescription.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 1 May 2025

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 1 May 2025

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 1 May 2025

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

2 official files

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.